Export Oncology

We are specialized in oral oncology drugs in form of tablets and hard/softgel capsules in our industry-leading infrastructure with quality manufacturing capabilities certified by most of the advanced regulatory authorities around the world, including US FDA, EU EMA, Japan PDMA, China FDA, and Brazil ANVISA.

With a faith in making a difference for people with cancer, we’ve achieved several milestones to increase the accessibility of affordable drugs to patients around the world, including the first-to-market with Lenalidomide in Europe, the successful launch of Gefitinib in 20 European markets on patent expiry date, and the first approval of generic Vinorelbine softgel capsules.

We have several products currently being approved or under registration in different countries around the world. Please contact us for detailed product list in your country.